Evidence map›Paper›PMID 23114371›Full record

ArticleThe Pediatric infectious disease journal2013

Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

Katherine Pandelidis, Amanda McCarthy, Kirsty L Chesko, Rose M Viscardi

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Randomised trial of azithromycin to eradicateArchives of disease in childhood. Fetal and neonatal edition · 2020
    Trial
  3. Trial
  4. Review
  5. International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Microorganisms · 2025
    Review
  11. Article
  12. Prevalence of Ureaplasma species among patients at a tertiary hospital in China: a 10-year retrospective study from 2013 to 2022.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  13. Lung Cancer Stage Prediction Using Multi-Omics Data.Computational and mathematical methods in medicine · 2022
    Article
  14. Article
  15. Frontiers in microbiology · 2020
    Article
  16. Possible shunt infection with Ureaplasma urealyticum in an ELBW preterm.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2019
    Article
  17. Article
  18. Detecting the Diversity ofFrontiers in microbiology · 2017
    Article
  19. Review
  20. Ureaplasma species: role in neonatal morbidities and outcomes.Archives of disease in childhood. Fetal and neonatal edition · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Katherine PandelidisDepartment of Pediatrics, University of Maryland, Baltimore, MD 21201, USA.
Amanda McCarthy
Kirsty L Chesko
Rose M Viscardi
Apple (Israel) · ILUniversity of Maryland, Baltimore · US

Funding

Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung InjuryR01HL087166 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI VISCARDI, ROSE MARIE · 2007 to 2011
$1.8M
Azithromycin to prevent BPD in Ureaplasma-infected Preterms: Single Dose PK studyR21HD056424 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI VISCARDI, ROSE MARIE · 2007 to 2009
$508k
NHLBI NIH HHS R01 HL087166NHLBI NIH HHS R01HL087166NICHD NIH HHS R21 HD056424NICHD NIH HHS R21HD056424
6 · The paper itself

Abstract

backgroundUreaplasma respiratory tract colonization is a risk factor for bronchopulmonary dysplasia (BPD) in preterm infants, but whether Ureaplasma isolates from colonized infants can form biofilms is unknown. We hypothesized that Ureaplasma isolates vary in capacity to form biofilms that contribute to their antibiotic resistance and ability to evade host immune responses. Study objectives were to (1) determine the ability of Ureaplasma isolates from preterm neonates to form biofilms in vitro; (2) compare the susceptibility of the sessile and planktonic organisms to azithromycin (AZI) and erythromycin; and (3) determine the relationship of biofilm-forming capacity in Ureaplasma isolates and the risk for BPD.

methodsForty-three clinical isolates from preterm neonates and 5 American Tissue Culture Collection strains were characterized for their capacity to form biofilms in vitro, and antibiotic susceptibility was performed on each isolate prebiofilm and postbiofilm formation.

resultsForty-one (95%) clinical and 4 of 5 (80%) American Tissue Culture Collection isolates formed biofilms. All isolates were more susceptible to AZI (minimum inhibitory concentration, MIC50 2 µg/mL) than erythromycin (MIC50 4 µg/mL), and biofilm formation did not significantly affect antibiotic susceptibility for the 2 tested antibiotics. The MIC50 and minimum biofilm inhibitory concentrations (MBIC50) for Ureaplasma urealyticum clinical isolates for AZI were higher than for MIC50 and MBIC50 for Ureaplasma parvum isolates. There were no differences in MIC or MBICs among isolates from BPD infants and non-BPD infants.

conclusionsCapacity to form biofilms is common among Ureaplasma spp. isolates, but biofilm formation did not impact MICs for AZI or erythromycin.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsBiofilmsBronchopulmonary DysplasiaHumansInfant, NewbornInfant, PrematureMicrobial Sensitivity TestsUreaplasma InfectionsUreaplasma urealyticumAnti-Bacterial Agents

Identifiers

PMID23114371
PMCPMC3600059
OpenAlexW2013891561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.